金十数据整理：每日港股市场要闻速递（12月30日周一）

美港电讯2024-12-30

【金十数据整理：每日港股市场要闻速递（12月30日周一）】个股新闻1. 摩根大通增持药明康德(02359.HK)约87.87万股，每股作价约55.04港元。2. 贝莱德增持理想汽车(02015.HK)约184.66万股，每股作价约92.98港元。3. 中国太保(02601.HK)：赵永刚担任太保寿险董事长的任职资格获核准。4. 碧桂园(02007.HK)附属拟以20亿元出售长鑫科技约1.56%的股本权益。5. 石四药集团(02005.HK)：对乙酰氨基酚片获国家药监局批准新增0.5g规格。6. 据港交所文件：沪上阿姨（上海）实业股份有限公司再次向港交所提交上市申请书。7. 优必选：董事会主席兼CEO周剑承诺未来一年不减持公司股份。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2495273551?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-30 09:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495273551","market":"us","top_or_hot":-1,"title":"金十数据整理：每日港股市场要闻速递（12月30日 周一）","media":"美港电讯","content":"<html><body><p>【金十数据整理：每日港股市场要闻速递（12月30日 周一）】<b>个股新闻</b><span>1. 摩根大通增持药明康德(02359.HK)约87.87万股，每股作价约55.04港元。</span><span>2. 贝莱德增持理想汽车(02015.HK)约184.66万股，每股作价约92.98港元。</span><span>3. 中国太保(02601.HK)：赵永刚担任太保寿险董事长的任职资格获核准。</span><span>4. 碧桂园(02007.HK)附属拟以20亿元出售长鑫科技约1.56%的股本权益。</span><span>5. 石四药集团(02005.HK)：对乙酰氨基酚片获国家药监局批准新增0.5g规格。</span><span>6. 据港交所文件：沪上阿姨（上海）实业股份有限公司再次向港交所提交上市申请书。</span><span>7. 优必选：董事会主席兼CEO周剑承诺未来一年不减持公司股份。</span></p></body></html>","source":"live_meigang","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金十数据整理：每日港股市场要闻速递（12月30日 周一）</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金十数据整理：每日港股市场要闻速递（12月30日 周一）\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">美港电讯</strong><span class=\"h-time small\">2024-12-30 09:09</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>【金十数据整理：每日港股市场要闻速递（12月30日 周一）】<b>个股新闻</b><span>1. 摩根大通增持药明康德(02359.HK)约87.87万股，每股作价约55.04港元。</span><span>2. 贝莱德增持理想汽车(02015.HK)约184.66万股，每股作价约92.98港元。</span><span>3. 中国太保(02601.HK)：赵永刚担任太保寿险董事长的任职资格获核准。</span><span>4. 碧桂园(02007.HK)附属拟以20亿元出售长鑫科技约1.56%的股本权益。</span><span>5. 石四药集团(02005.HK)：对乙酰氨基酚片获国家药监局批准新增0.5g规格。</span><span>6. 据港交所文件：沪上阿姨（上海）实业股份有限公司再次向港交所提交上市申请书。</span><span>7. 优必选：董事会主席兼CEO周剑承诺未来一年不减持公司股份。</span></p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.ushknews.com/\">美港电讯</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1917777945.USD","symbol_name":"安联专题基金Cl AT Acc","start_time":0,"source_url":"https://www.ushknews.com/","article_id":"2495273551","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495273551","pubTimestamp":1735520988,"columns":[],"sourceInfo":{"source_id":"live_meigang","name":"美港电讯"},"weMediaInfo":null,"summary":"【金十数据整理：每日港股市场要闻速递（12月30日 周一）】个股新闻1. 摩根大通增持药明康德(02359.HK)约87.87万股，每股作价约55.04港元。2. 贝莱德增持理想汽车(02015.HK","collect":0,"end_time":0,"defaultTopTitle":"ushknews.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"601601":"中国太保","603259":"药明康德","LU1917777945.USD":"安联专题基金Cl AT Acc","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","IE0034235295.USD":"PINEBRIDGE GLOBAL DYNAMIC ASSET ALLOCATION \"A\" (USD) ACC","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK0028":"国家队","09880":"优必选","BLK":"贝莱德","02601":"中国太保","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU0772969993.USD":"FIDELITY GLOBAL DIVIDEND \"A\" (USD) ACC","YANG":"三倍做空富时中国ETF-Direxion","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","HSCEI":"国企指数","02359":"药明康德","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","02015":"理想汽车-W","LU0234572021.USD":"高盛美国核心股票组合Acc","IE00BKDWB100.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5H\" (SGDHDG) ACC","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","EVS.SI":"MSCI China Electric Vehicles and Future Mobility ETF-NikkoAM","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","HSTECH":"恒生科技指数","02005":"石四药集团","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","BK4551":"寇图资本持仓","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","02007":"碧桂园","BK1521":"挪威政府全球养老基金持仓","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU1032466523.USD":"高盛全球多资产收益组合Acc","07226":"XL二南方恒科","BK1183":"工业机械","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU2242649171.HKD":"FIDELITY FUNDS GLOBAL THEMATIC OPPORTUNITIES \"A\" (HKD) ACC","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LI":"理想汽车"},"translate_title":"Golden Ten Data Compilation: Daily Hong Kong Stock Market News Express (Monday, December 30)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601601":1,"603259":1,"02007":1,"YANG":1,"LI":1,"HSTECH":1,"HSCEI":1,"BLK":1,"09880":1,"02005":1,"02015":1,"02359":1,"02601":1,"07226":1,"EVS.SI":0.6},"content_text":"【金十数据整理：每日港股市场要闻速递（12月30日 周一）】个股新闻1. 摩根大通增持药明康德(02359.HK)约87.87万股，每股作价约55.04港元。2. 贝莱德增持理想汽车(02015.HK)约184.66万股，每股作价约92.98港元。3. 中国太保(02601.HK)：赵永刚担任太保寿险董事长的任职资格获核准。4. 碧桂园(02007.HK)附属拟以20亿元出售长鑫科技约1.56%的股本权益。5. 石四药集团(02005.HK)：对乙酰氨基酚片获国家药监局批准新增0.5g规格。6. 据港交所文件：沪上阿姨（上海）实业股份有限公司再次向港交所提交上市申请书。7. 优必选：董事会主席兼CEO周剑承诺未来一年不减持公司股份。","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2495273551"}

金十数据整理：每日港股市场要闻速递（12月30日 周一）

精彩评论

金十数据整理：每日港股市场要闻速递（12月30日周一）